Lv5
820 积分 2024-07-17 加入
BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile
1个月前
已完结
Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
1个月前
已完结
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
1个月前
已完结
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
1个月前
已完结
Synthetic lethality in cancer drug discovery: challenges and opportunities
1个月前
已完结
Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes
3个月前
已完结
Critical role of the potential O-linked glycosylation sites of CXCR4 in cell migration and bone marrow homing of hematopoietic stem progenitor cells
3个月前
已关闭
Hematopoietic Stem Cell Development in Mammalian Embryos
3个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
3个月前
已完结
A genome-wide screen identifies Runx2 as a novel regulator of hematopoietic stem cell expansion and T-cell commitment
3个月前
已完结
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma
皖公网安备34019202002308
